ArticleJournal of current ophthalmology
Comparative Evaluation of Water Drinking Test Response in Advanced Glaucoma Patients with Prior Preserflo MicroShunt and Trabeculectomy Surgery.
Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the differences in intraocular pressure (IOP) response to the water drinking test (WDT) in advanced glaucoma patients following trabeculectomy or Preserflo MicroShunt implantation. Methods: This prospective study included 30 eyes from 29 advanced glaucoma patients: 15 underwent trabeculectomy, and 15 received the Preserflo MicroShunt. Baseline IOP was measured using Goldmann applanation tonometry, followed by WDT involving the consumption of 10 mL of water per kilogram of body weight over 5 min. IOP was measured at 15-min intervals until it returned to baseline. Outcomes included peak IOP, time to peak IOP, IOP fluctuation, and time to return to baseline. Results: Baseline IOP was comparable between groups (trabeculectomy: 14.83 ± 2.28 mmHg; Preserflo: 15 ± 1.23 mmHg, Conclusions: Both trabeculectomy and the Preserflo MicroShunt effectively controlled IOP during WDT, with the Preserflo MicroShunt demonstrating noninferiority in overall IOP control. Trabeculectomy exhibited superior dynamic outflow capacity, making it suitable for patients requiring aggressive IOP reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.